Private Trust Company’s Cymabay Therapeutics CBAY Stock Holding History

Private Trust Company’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-340	Closed	-$8.03K	–	2382
2023 Q4	$8.03K	Buy	340 +28	+9%	+$499	﹤0.01%	1732
2023 Q3	$4.65K	Buy	+312	New	+$4.14K	﹤0.01%	1901

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Private Trust Company's CBAY Position: Q1 2024 in Review

Private Trust Company sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 340 shares — an estimated $8.03K sold.

Private Trust Company first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $8.03K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Private Trust Company reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Private Trust Company sold 340 Cymabay Therapeutics shares in Q1 2024, an estimated $8.03K.
Private Trust Company first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
Private Trust Company's Cymabay Therapeutics position peaked at $8.03K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Private Trust Company's 13F filing for Q1 2024, filed 24 Apr 2024.